Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Pozycja w akcjach #425
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health... Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Cena akcji
$116.80
Kapitalizacja rynkowa
$51.47B
Zmiana (1 dzień)
0.75%
Zmiana (1 rok)
-27.59%
Kraj
US
Handel Zoetis Inc. (ZTS)

Kategoria

Marża operacyjna dla Zoetis Inc. (ZTS)
Marża operacyjna na dzień March 2026 TTM: 38.00%
Według najnowszych raportów finansowych i ceny akcji Zoetis Inc., bieżąca marża operacyjna (TTM) wynosi 38.00%. Na koniec 2023 wynosiła 35.92%.
Historia marży operacyjnej dla Zoetis Inc. od 2009 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) 38.00% 3.68%
2024 36.65% 2.03%
2023 35.92% -0.88%
2022 36.24% 0.53%
2021 36.05% 6.06%
2020 33.99% 5.43%
2019 32.24% -0.15%
2018 32.29% -0.77%
2017 32.54% 13.30%
2016 28.72% 26.46%
2015 22.71% 12.04%
2014 20.27% 12.61%
2013 18.00% -8.63%
2012 19.70% 21.91%
2011 16.16% 87.25%
2010 8.63% -15.23%
2009 10.18% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
20.15% -99.47%
DE
20.30% -99.47%
FR
10.28% -99.73%
JP
253.25% -93.34%
IL
20.49% -99.46%
GB
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.